Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2015
July 2015, Vol 6, No 6
Laura Morgan
Authored Articles
ASCO Names the 14 Oncology Practices Participating in the 2016 Quality Training Program, Highlighting Significant Improvements in Care Delivery
Laura Morgan
Oncology Practice
October 2016, Vol 7, No 9
Read Article
New Anticancer Drugs Increase Costs but Prolong Life
Laura Morgan
Value in Oncology
October 2016, Vol 7, No 9
Read Article
NCI’s Acting Director: Data-Sharing, Immunotherapy, and the Cancer Moonshot Initiative
Laura Morgan
Cancer Moonshot
September 2016, Vol 7, No 8
Read Article
Defitelio (Defibrotide Sodium): First Drug Approved for Patients with Hepatic Veno-Occlusive Disease
Laura Morgan
Drug Updates
July 2016, Vol 7, No 6
Read Article
Osimertinib Effective for First-Line Treatment of EGFR Mutation–Positive NSCLC
Laura Morgan
Lung Cancer
,
Solid Tumors
June 2016, Vol 7, No 5
Read Article
American Cancer Society Updates Breast Cancer Screening Guidelines for Women at Average Risk
Laura Morgan
Breast Cancer
,
Solid Tumors
December 2015, Vol 6, No 11
Read Article
Patients with Cancer Eager to Discuss Costs of Care with Their Oncologists
Laura Morgan
Economics & Value
,
Economics of Cancer Care
September 2015, Vol 6, No 8
Read Article
Medical and Psychosocial Impact of Oral Therapy on Patients with Metastatic Castration-Resistant Prostate Cancer
Laura Morgan
Prostate Cancer
,
Solid Tumors
September 2015, Vol 6, No 8
Read Article
ASCO Develops New Framework to Evaluate the Value of Cancer Therapies
Laura Morgan
ASCO’s Value Framework
July 2015, Vol 6, No 6
Read Article
Biomarker Testing Trends in Europe Linked to Availability of Specific Targeted Cancer Drugs
Laura Morgan
Personalized Medicine
June 2015, Vol 6, No 5
Read Article
The New PC-SAF Instrument: A Patient-Reported Outcome Tool for Identifying the Symptoms of Pancreatic Cancer
Laura Morgan
Economics & Value
,
Economics of Cancer Care
June 2015, Vol 6, No 5
Read Article
Increasing Use of Value Analysis Committees in US Hospitals: Implications for Healthcare Providers and Manufacturers
Laura Morgan
Economics & Value
,
Economics of Cancer Care
June 2015, Vol 6, No 5
Read Article
Early Initiation of Palliative Care Improves Survival in Patients with Advanced Cancer
Laura Morgan
Palliative Care
,
Personalized Medicine
June 2015, Vol 6, No 5
Read Article
Health Plan Cost-Savings with Netupitant/Palonosetron for the Prevention of CINV
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
Read Article
Real-World Treatment Patterns of Axitinib for Advanced Renal-Cell Carcinoma
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
Read Article
Substantial Costs Associated with Systemic Therapy After Ipilimumab in Patients with Advanced Melanoma
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
Read Article
Medicare’s Sustainable Growth Rate Repeal Met with Relief
Laura Morgan
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
Read Article
Comparing the Safety and Efficacy of Stereotactic Radiotherapy versus Surgery in Lung Cancer
Laura Morgan
Lung Cancer
,
Solid Tumors
October 2014, Vol 5 , No 8
Read Article
IOM’s Call to Action on End-of-Life Care in the United States
Laura Morgan
End-of-Life Care
,
Policies & Guidelines
October 2014, Vol 5 , No 8
Read Article
Oncologists Show Low Genomic Confidence about the Use of Genetic Testing
Laura Morgan
Personalized Medicine
September 2014, Vol 5, No 7
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma